Content about Branded

April 15, 2011
Credit Suisse: Rising gas prices may rev drug engine

Drug stores may be best positioned to navigate any headwinds whipped up by rising fuel costs and may even benefit from them, a Credit Suisse analysis published Friday found.

April 15, 2011
PhRMA honors scientists that helped discover Januvia

The main trade group representing branded drug makers gave an award to two Merck scientists who helped discover an oral medication for Type 2 diabetes.

April 15, 2011
Takeda's Edarbi enters market

Takeda Pharmaceutical has launched a new treatment for high blood pressure, the company said Friday.

April 14, 2011
CVS Caremark's report highlights lowest drug trend in six years

Despite a difficult economy and rising health costs, the benefits of an integrated pharmacy service were evident as CVS Caremark helped its pharmacy benefit manager clients — employers, health plans and third-party administrators — manage pharmacy costs, according to the company's annual "Insights Report."

April 14, 2011
FDA: Certain TNF blockers could be linked to rare cancer

The Food and Drug Administration has received reports of a rare and usually deadly cancer in patients using a class of biotech drugs to treat autoimmune and inflammatory diseases, the agency said Thursday.

April 14, 2011
Report: Drug makers look to create new erectile dysfunction treatments

Drug manufacturers are coming up with new versions of their drugs for erectile dysfunction as those drugs’ loss of patent protection and subsequent generic competition draw near, according to published reports.

April 13, 2011
Cephalon files bid document for ChemGenex

Cephalon has lodged a bidder’s statement to acquire Australian drug maker ChemGenex Pharmaceuticals for $167 million, Cephalon said Wednesday.

April 13, 2011
FDA accepts regulatory application for Bio-T-Gel

The Food and Drug Administration has accepted a regulatory approval application for a topical treatment for low testosterone made by Teva Pharmaceuticals and BioSante Pharmaceuticals, BioSante said Wednesday.

April 13, 2011
FDA advisory committee recommends approval for Pfizer's Sutent

A Food and Drug Administration expert panel has given a favorable vote to a drug made by Pfizer for tumors, Pfizer said Tuesday.

April 12, 2011
Express Scripts: Aligning patient behavior, intentions could save money for healthcare system

The road to waste reduction is paved with good intentions.

April 12, 2011
Former GSK executive named Safeway SVP

Darren Singer, a 25-year GlaxoSmithKline veteran, has been named Safeway's SVP pharmacy, health and wellness, the retailer announced.

April 12, 2011
Sylatron OKed as add-on melanoma treatment

The Food and Drug Administration has approved a treatment made by Merck for treating skin cancer, Merck said Monday.

April 12, 2011
Teva, Active Biotech: Laquinimod reduces relapses, disease progression in MS patients

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

April 11, 2011
Endo to acquire American Medical Systems

Endo Pharmaceuticals will buy American Medical Systems for $2.9 billion, the drug maker said Monday.

April 11, 2011
Invega approved as schizophrenia treatment for adolescents

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

April 11, 2011
Pfizer, Medivation 'disappointed' in phase-3 trial results for Dimebon

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

April 11, 2011
Sanofi-Aventis closes Genzyme acquisition

Genzyme now officially is a wholly owned subsidiary of Sanofi-Aventis.

April 8, 2011
Novo Nordisk honored by National Hemophilia Foundation

Danish drug maker Novo Nordisk has received the Corporate Leadership Award from the National Hemophilia Foundation in response to its research and development efforts for the disease, the company said Friday.

April 8, 2011
Regeneron, Bayer commence phase-3 trial for diabetic macular edema treatment

Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

April 8, 2011
Watson faces patent challenge over generic Vigamox

Watson announced that its subsidiary is seeking approval to market a generic version of a bacterial conjunctivitis treatment.

April 7, 2011
AstraZeneca's vandetanib receives approval from FDA

The Food and Drug Administration has approved a drug made by AstraZeneca for treating a rare form of thyroid cancer, the agency said.

April 7, 2011
Horizant OKed as restless legs syndrome treatment

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and Xenoport for treating restless legs syndrome, the agency said Thursday.

April 7, 2011
Pfizer, Zacharon enter collaboration

Pfizer is partnering with San Diego biotech company Zacharon Pharmaceuticals to develop treatments for rare genetic disorders Zacharon said Thursday.

April 6, 2011
Generex unveils updated corporate website

Generex Biotechnology has revamped its corporate website to underscore the company's focus on the development and approval of its diabetes and immunotherapeutic vaccine products pipeline.

April 6, 2011
Shire files lawsuit against Watson over Adderall XR

British drug maker Shire has filed suit against Watson Pharmaceuticals and subsidiaries, alleging patent infringement in a case concerning a drug used to treat attention deficit hyperactivity disorder.

© 2013 Drug Store News. All Rights Reserved.